Analgesics in the UK is posting value growth in 2026 but momentum is slowing compared to the strong gains observed in other consumer health areas, reflecting a move towards preventive health and reduced demand for symptom-driven products. The environment remains attractive for manufacturers that can adapt, with pharmacies consolidating their role as the leading channel by leveraging trust, advice, and immediate access, especially under NHS constraints and the Pharmacy First initiative. Growth is increasingly shaped by the rise of combination and topical formats, value-conscious purchasing, and the shift of consumer spend towards adjacent wellness and nutrition solutions; brands that focus on innovation, cleaner formulations, and strong partnerships with pharmacies are best positioned to maintain or grow share in an evolving landscape where private label and non-traditional competitors are gaining ground.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in United Kingdom with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in United Kingdom, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in United Kingdom report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in United Kingdom?
- Which are the leading brands in Analgesics in United Kingdom?
- How are products distributed in Analgesics in United Kingdom?
- How has the regulatory and operating environment for Analgesics changed in United Kingdom?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Pharmacies drive analgesics sales as consumers seek advice and immediate relief
Nuromol gains ground as budget-conscious shoppers seek stronger combination pain relief
Liquid I.V. and Berocca attract proactive shoppers as prevention eclipses symptom relief
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Combination solutions and holistic prevention to reshape pain relief habits
Pharmacy First and private label to drive trust and affordability in pain care
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies and supermarkets sustain dominance as trusted destinations
Retail e-commerce struggles to displace traditional pain relief channels
Chart 1 Retail Channels 2021-2026
Combination formulations and cleaner labels drive product-level innovation
Nuromol and Solpadine anchor combination analgesics while private label captures value
Prevention trend and channel dynamics compress long-term growth prospects
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!